- Clinical trials are research studies that test whether a new treatment is safe and effective; they are research, not guaranteed treatment.
- Crohn's disease research includes new biologics, small-molecule drugs, dietary approaches, and studies of hard-to-treat disease.
- You can search current studies on ClinicalTrials.gov, a US government registry of clinical trials.
- Informed consent means you get full information about a study, can ask questions, and can withdraw at any time.
- Eligibility rules (inclusion and exclusion criteria) determine who can join a given trial.
- Discuss any trial with your gastroenterologist, and never stop your current Crohn's medications on your own.
Crohn’s disease is a chronic inflammatory bowel condition, and research continues to expand the treatment options available, especially for people whose symptoms are hard to control. Clinical trials are one of the ways new therapies are tested. But a trial is a research study, not guaranteed treatment, so it helps to understand how they work before considering one. This guide explains what Crohn’s disease clinical trials are, the phases involved, how to find studies, and what informed consent means, so you can have a well-prepared conversation with your gastroenterologist.
What is a clinical trial?
A clinical trial is a research study that tests a medical approach, such as a new medication, biologic, or dietary strategy, in people. The goal is to answer specific questions: Is it safe? What dose works best? Does it help more than existing options or a placebo? Because these questions are still being answered, participation involves some uncertainty. A trial is designed to generate knowledge, and while participants may benefit, benefit is never guaranteed and is not the study’s only purpose.
Crohn’s disease research is active. Trials may study new biologic medications, small-molecule drugs, combination regimens, nutritional therapies, and approaches for people with moderate-to-severe or treatment-resistant disease. Some studies focus on inducing remission, and others on maintaining it over time.
The phases of drug trials
New drugs generally move through a series of phases, each with a different question and size.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what is a tolerable dose? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo? | Large groups, often at multiple sites |
| Phase 4 | What are the long-term effects after approval? | Post-approval monitoring |
Many trials use a control group and randomization, and some are “blinded,” meaning participants (and sometimes researchers) do not know who receives the investigational treatment versus a comparison. These designs help produce reliable answers, but they also mean you may not receive the new treatment. The same structure applies across clinical trials for other conditions.
How to search for Crohn’s disease trials
The main US resource is ClinicalTrials.gov, a registry run by the National Institutes of Health that lists clinical studies conducted around the world. You can search by condition (such as “Crohn’s disease” or “inflammatory bowel disease”), location, and recruitment status. Each listing describes the study’s purpose, eligibility criteria, locations, and contact information. Academic gastroenterology centers and patient advocacy organizations often share trial opportunities as well. As you read listings, note the eligibility rules: inclusion criteria (characteristics you must have, often including disease severity or prior treatments) and exclusion criteria (things that would keep you out). For context on how research and everyday care fit together, our evidence-first wellness guides take a careful approach throughout.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and you can decline without affecting your regular care.
- You can withdraw from a study at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board) that helps protect participants.
- You should understand any costs, travel, time commitment, procedures such as endoscopies, and what happens when the study ends.
Consent is an ongoing conversation, not just a signature. Ask as many questions as you need.
Talk with your gastroenterologist first
Joining a trial is a medical decision, so involve the doctor who manages your Crohn’s disease. Your gastroenterologist can help you weigh whether a study fits your situation, what the realistic pros and cons are, and how it interacts with your current treatment. Crucially, never stop or change your existing Crohn’s medications on your own to qualify for or join a trial; abrupt changes can trigger flares. Let your care team and the research team coordinate any changes safely. If you are exploring research across health areas, you can also see how weight-loss studies are run.
Frequently asked questions
Will a clinical trial cure my Crohn’s disease? No trial can promise that. Trials test whether treatments are safe and effective; participation is research, and benefit is possible but not guaranteed.
Where do I find Crohn’s trials? ClinicalTrials.gov is the main US registry. Academic IBD centers and advocacy groups also list opportunities.
Do I have to pay to join? Study treatment is often provided, but costs vary. Ask about any expenses, travel, and what is covered before enrolling.
Might I receive a placebo? In some trials, yes, though many maintain your standard care alongside the study. The consent process will explain exactly what each group receives.
Can I leave a trial after starting? Yes. Participation is voluntary, and you can withdraw at any time without losing access to your standard care.
Should I stop my current medication to qualify? Never do this on your own. Any change must be guided by your gastroenterologist and the research team to avoid flares.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Crohn’s disease and IBD research
- MedlinePlus — Crohn’s disease and clinical trials overviews
- U.S. Food and Drug Administration (FDA) — clinical trial phases and drug development